Creative Biolabs Supplies Multiple Engineered Antibody Products

  • The advanced hybridoma development and phage display platforms enable the production of the most comprehensive recombinant antibody products and the provision of an extensive portfolio of services at the most competitive price in the industry at Creative Biolabs. The engineered antibodies greatly advance the research projects of global customers who are studying diseases and new therapeutic methods.


    Blocking Antibody

    With various clinical and experimental applications, blocking antibody is receiving increasing attention in studies, which does not react with antigen when combining but prevents other combinations, playing a role in clinical uses that it can prevent the harmful substance from binding to the cell.

    Hot targets: ERBB2, TNF, CD19, IL2, CD33, etc.

    Neutralizing Antibody

    A neutralizing antibody can block the infections through neutralizing or inhibiting the biological effect of the infectious agent, which is produced by the immune system as natural immune prevention. Creative Biolabs supplies various antibodies validated for neutralizing, which have been tested in relevant bioassays to ensure appropriate cellular functions.

    Hot targets: BMP2, EGFR, TNF, CD19, MS4A1, etc.

    Anti-idiotypic Antibody

    Anti-idiotypic antibody (anti-ID antibody) specifically binds to the antigen-binding site of an antibody, which can be classified into Type I anti-ID (the target idiotope is within CDR), Type II anti-ID (the target idiotope is within FR), Type III anti-ID (partially blocks antigen-antibody interaction), and Type IV anti-ID (recognizes the idiotopes of both antibody and antigen).

    Hot targets: Trastuzumab, Bevacizumab, Rituximab, Cetuximab, etc.

    Agonistic Antibody

    Agonistic antibodies can work as agonists of the receptors. Creative Biolabs provides agonistic antibody products against the tumor necrosis factor (TNF) family, such as CD27, CD40, and OX40 to support the research on therapeutic antibodies of agonism mechanism of action.

    Hot targets: CD40, CD27, TNFRSF10B, TNFRSF1A, etc.

    Additional to the above-mentioned engineered antibody products, chimeric antigen receptor (CAR) products and antibody-drug conjugate (ADC) products are also available at attractive prices. With the support of the team of specialized scientists, custom antibody discovery and engineering, phage display library construction, antibody humanization, and other solutions serve the clients in need of technical support. Explore more at